TRIBUTARY LLP for CHRO ASSOCIATION (FKA HR POLICY ASSOCIATION)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HCR7/7/2022Meeting with Sen. McConnell staff re: drug pricing HCR7/7/2022Meeting with Sen. Portman staff re: drug pricing HCR7/12/2022Meeting with Sen. Toomey staff re: drug pricing HCR7/12/2022Meeting with Sen.Thune staff re: drug pricing HCR7/12/2022Meeting with Senate HELP staff re: drug pricing HCR7/13/2022Meeting with Sen. Boozman staff re: drug pricing HCR7/13/2022Meeting with Sen. Tillis staff re: drug pricing HCR7/14/2022Letter to House and Senate in support of H.R. 8297, the Ensuring Access to Abortion Act and S.4504, the Freedom to Travel for Health Care Act HCR7/14/2022Meeting with OMB on surprise billing HCR7/14/2022Meeting with Sen. Barrasso staff re: drug pricing HCR7/14/2022Meeting with Sen. Hawley staff re: drug pricing HCR7/14/2022Meeting with Sen. Lummis staff re: drug pricing HCR7/14/2022Meeting with Sen. Young staff re: drug pricing HCR7/14/2022Meeting with Senate Finance staff re: drug pricing HCR7/15/2022Meeting with Sen. Lummis staff re: drug pricing HCR7/18/2022Meeting with Sen. Marshall staff re: drug pricing HCR7/19/2022Meeting with Sen. Fischer staff re: drug pricing HCR7/20/2022Meeting with Senate HELP maj. Staff re. drug pricing HCR7/25/2022Meeting with Sen. Braun staff re: drug pricing HCR7/28/2022Meeting with Sen. Tuberville staff re: drug pricing HCR7/29/2022Meeting with Sen Finance Maj. Staff re: drug pricing HCR7/31/2022Meeting with Rep. Graves staff re: ESRD HCR8/1/2022Meeting with DOL Employee Benefits Security Administration re Dobbs v. Jackson Womens Health Organization HCR8/15/2022Meeting with Ways & Means Maj re: reporting HCR9/6/2022Meeting with Rep. Meuser re: ESRD HCR9/14/2022Meeting with Sen Finance Maj. Staff re: ESRD HCR9/16/2022Meeting with E & C Maj. re: ESRD HCR9/21/2022Meeting with Sen. HELP re: ESDRD HCR9/22/2022Meeting with Rep. Thompson re: ESRD and reporting HCR9/23/2022Meeting with DOL re: mental health parity HCR9/28/2022Meeting with Ways & Means Maj re: ESRD
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY J BARTL | Rep. Steve Gunderson-Legislative Director/Counsel, Leg. Assistant, Leg. Correspondent |
| CHATRANE BIRBAL New | — |
| DANIEL CHASEN | Rep. Chuck Fleischmann, Intern |
| MARGARET FASO | — |
Labor Issues/Antitrust/Workplace LBR
LBR7/13/2022Letter to House in opposition to labor provisions in H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 LBR9/6/2022Meeting with Senate Armed Services Committee Staff on Contractor Debarment re H.R.7900 LBR9/13/2022Meeting with Senate HELP Committee Staff on Contractor Debarment re H.R. 7900 LBR9/27/2022Meeting with Senate Judiciary Committee Staff on Contractor Debarment re H.R. 7900 LBR9/29/2022Letter to Senate in opposition to labor provisions in H.R. 7900, National Defense Authorization Act for Fiscal Year 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY J BARTL | Rep. Steve Gunderson-Legislative Director/Counsel, Leg. Assistant, Leg. Correspondent |
| CHATRANE BIRBAL New | — |
| DANIEL CHASEN | Rep. Chuck Fleischmann, Intern |
| MARGARET FASO | — |
Financial Institutions/Investments/Securities FIN
FIN8/8/2022Meeting w/ Commissioner Noah Phillips re FTC Anticipated Rulemaking on Noncompete Clauses FIN9/13/2022Meeting w/ FTC staff re Anticipated Rulemaking on Noncompete Clauses
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY J BARTL | — |
| CHATRANE BIRBAL New | — |
| DANIEL CHASEN | Rep. Chuck Fleischmann, Intern |
| MARGARET FASO | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SAMSUNG | South Korea | South Korea | — | $2,968 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.